Clinical Trials Browser

Active not recruiting × Pancreatic Adenocarcinoma × 90 days × Clear all

NCT05973331 2026-04-22

Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

Active not recruiting

6,134,060 enrolled

Gastrointestinal

Pancreatic Adenocarcinoma

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma